Medil AI

How Medil AI handles medication information in Singapore

For people in Singapore, Medil AI combines personal organization tools with medication information. This page explains the role of HSA sources, the limits of local coverage, and what must be checked in the current official record.

Official Singapore source

Singapore official sources

The HSA Register of Therapeutic Products is the primary public reference for a product's Singapore registration status and available approved Package Insert or Patient Information Leaflet. Not every PI or PIL is available online, and availability can change.

Official Singapore source

Information from other markets

A clearly labelled official reference from another market may provide context, but it does not establish Singapore registration, availability, indication or approved wording. The current HSA record remains the local reference.

AI-assisted explanation

AI summaries and translations

AI-assisted summaries and translations are labelled. They may omit context or contain errors and are not HSA documents. Check the original official record and consult a qualified healthcare professional when needed.

Medil product guidance

Questions sent to an external AI service

When preparing a question, the user chooses which context to include and reviews it before continuing. Nothing is sent to the selected external service until the user continues.

Medil product guidance

Updates, quality checks and review status

Medil AI performs automated consistency checks and Android and iOS release checks. This is editorial product-and-source guidance, not medically reviewed clinical interpretation, and it is not a real-time copy of the HSA register.

Official Singapore source

Singapore official sources

Singapore coverage limitation

Medil AI does not determine whether a product may be supplied or used in Singapore. Confirm registration status and current approved information in the HSA register and confirm medication decisions with a qualified healthcare professional.